ALTMAN MICHAEL SETH 4
4 · Nautilus Biotechnology, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
ALTMAN MICHAEL SETH
DirectorChief Financial Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2023-06-15+45,000→ 45,000 totalExercise: $3.97Exp: 2033-06-15→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date.